New Age Alpha Advisors, LLC Alkermes Plc. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 13,702 shares of ALKS stock, worth $401,879. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,702
Previous 5,937
130.79%
Holding current value
$401,879
Previous $171 Million
164.98%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$854 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$534 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$346 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$235 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$202 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.82B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...